Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning

Zhao,Wang,Yang,Zhao,Sun,Chen

DOI: https://doi.org/10.3390/molecules29112681

IF: 4.6

2024-06-06

Molecules

Abstract:CDK6 plays a key role in the regulation of the cell cycle and is considered a crucial target for cancer therapy. In this work, conformational transitions of CDK6 were identified by using Gaussian accelerated molecular dynamics (GaMD), deep learning (DL), and free energy landscapes (FELs). DL finds that the binding pocket as well as the T-loop binding to the Vcyclin protein are involved in obvious differences of conformation contacts. This result suggests that the binding pocket of inhibitors (LQQ and AP9) and the binding interface of CDK6 to the Vcyclin protein play a key role in the function of CDK6. The analyses of FELs reveal that the binding pocket and the T-loop of CDK6 have disordered states. The results from principal component analysis (PCA) indicate that the binding of the Vcyclin protein affects the fluctuation behavior of the T-loop in CDK6. Our QM/MM-GBSA calculations suggest that the binding ability of LQQ to CDK6 is stronger than AP9 with or without the binding of the Vcyclin protein. Interaction networks of inhibitors with CDK6 were analyzed and the results reveal that LQQ contributes more hydrogen binding interactions (HBIs) and hot interaction spots with CDK6. In addition, the binding pocket endures flexibility changes from opening to closing states and the Vcyclin protein plays an important role in the stabilizing conformation of the T-loop. We anticipate that this work could provide useful information for further understanding the function of CDK6 and developing new promising inhibitors targeting CDK6.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The problem this paper attempts to address is: by combining Gaussian accelerated molecular dynamics (GaMD) and deep learning (DL), to reveal the conformational changes of CDK6 when binding with Vcyclin protein and inhibitors. Specifically, the study aims to: 1. **Identify the conformational transitions of CDK6**: Using GaMD, DL, and free energy landscapes (FELs) methods, identify the conformational changes of CDK6 in different binding states. 2. **Analyze key residue contacts**: Through DL methods, determine the key residue contacts of CDK6 when binding with Vcyclin protein and inhibitors, and the impact of these contacts on conformational changes. 3. **Evaluate the flexibility of the binding pocket**: Using FELs and PCA methods, analyze the flexibility changes of the CDK6 binding pocket, and the impact of Vcyclin protein and different inhibitors on these changes. 4. **Compare the effects of different inhibitors**: By calculating binding free energy and interaction networks, compare the effects of two inhibitors, LQQ and AP9, on the binding ability and stability of CDK6. Through these studies, the authors hope to provide valuable information for a deeper understanding of the function of CDK6 and its potential as a target for cancer therapy, and to provide theoretical support for the development of new, efficient inhibitors.

Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning

Immunomodulatory Effects of CDK4/6 Inhibitors

Effect of Substituents in Different Positions of Aminothiazole Hinge-Binding Scaffolds on Inhibitor–CDK2 Association Probed by Interaction Entropy Method

Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations

Highlighting the Major Role of Cyclin C in Cyclin-Dependent Kinase 8 Activity through Molecular Dynamics Simulations

All-Atomic Molecular Dynamic Studies of Human and Drosophila CDK8: Insights into Their Kinase Domains, the LXXLL Motifs, and Drug Binding Site

Molecular Principle of the Cyclin-Dependent Kinase Selectivity of 4-(Thiazol-5-yl)-2-(phenylamino) Pyrimidine-5-carbonitrile Derivatives Revealed by Molecular Modeling Studies.

Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations

A Robust Computational Framework for the Optimization of CDK7 Inhibitors as Promising Cancer Therapy

Elucidating Binding Selectivity in Cyclin-Dependent Kinases (CDKs) 4, 6, and 9: Development of Highly Potent and Selective CDK4/9 Inhibitors

Identification of natural marine compounds as potential inhibitors of CDK2 using molecular docking and molecular dynamics simulation approach

Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation

Elucidating the Selective Mechanism of Drugs Targeting Cyclin-Dependent Kinases with Integrated MetaD-US Simulation

Slower CDK4 and faster CDK2 activation in the cell cycle

Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl)pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2/4/6

Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning

Abstract 526: Identification of CDK6 binding proteins by proximity labeling reveals novel mechanisms for CDK4/6 inhibitor resistance in breast cancer

Potent inhibitors targeting Cyclin-dependent kinase 9 discovered via virtual high-throughput screening and absolute binding free energy calculations

High-throughput discovery and deep characterization of cyclin-CDK docking motifs

Identification of Potent CDK9 Inhibitors with Novel Skeletons Via Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation

Binding Modes and Conformational Changes of FK506-binding Protein 51 Induced by Inhibitor Bindings: Insight into Molecular Mechanisms Based on Multiple Simulation Technologies